BindingDB logo
myBDB logout

26 articles for Banyu Tsukuba Research Institute

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
18468891 Identification of novel benzimidazole series of potent and selective ORL1 antagonists. 30-MAY-2008 15-DEC-2012
11831911 Cyclohexylmethylpiperidinyltriphenylpropioamide: a selective muscarinic M(3) antagonist discriminating against the other receptor subtypes. 08-FEB-2002 27-NOV-2012
20005101 Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. 03-FEB-2010 01-SEP-2010
19736020 The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators. 16-SEP-2009 31-AUG-2010
19726182 Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators. 14-SEP-2009 30-AUG-2010
19589677 Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors. 29-JUL-2009 27-AUG-2010
19604695 Synthesis and biological evaluation of imidazole derivatives as novel NOP/ORL1 receptor antagonists: exploration and optimization of alternative pyrazole structure. 29-JUL-2009 27-AUG-2010
19540111 Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators. 14-JUL-2009 27-AUG-2010
19362831 Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators. 04-MAY-2009 26-AUG-2010
19427223 Structure-activity relationships of 3,5-disubstituted benzamides as glucokinase activators with potent in vivo efficacy. 19-MAY-2009 26-AUG-2010
19188063 Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators. 23-FEB-2009 11-JAN-2010
18723347 Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives. 15-SEP-2008 11-JAN-2010
18448337 Novel ORL1-selective antagonists with oral bioavailability and brain penetrability. 30-MAY-2008 11-JAN-2010
19282189 Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators. 30-MAR-2009 11-JAN-2010
18752943 Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists. 15-SEP-2008 11-JAN-2010
10340602 Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506. 19-AUG-1999 10-NOV-2009
16621546 Design, synthesis, and biological evaluation of indole derivatives as novel nociceptin/orphanin FQ (N/OFQ) receptor antagonists. 01-JUN-2006 10-NOV-2009
11354381 Discovery of a novel CCR3 selective antagonist. 16-MAY-2001 10-NOV-2009
16682184 Identification of potent 5-pyrimidinyl-2-aminothiazole CDK4, 6 inhibitors with significant selectivity over CDK1, 2, 5, 7, and 9. 05-JUN-2006 10-NOV-2009
12467628 Development of an orexin-2 receptor selective agonist, [Ala(11), D-Leu(15)]orexin-B. 06-DEC-2002 10-NOV-2009
16451050 Identification of a novel spiropiperidine opioid receptor-like 1 antagonist class by a focused library approach featuring 3D-pharmacophore similarity. 02-FEB-2006 10-NOV-2009
11844687 A new class of type I protein geranylgeranyltransferase (GGTase I) inhibitor. 14-FEB-2002 10-NOV-2009
10743939 Synthesis and biological activities of NB-506 analogues modified at the glucose group. 26-JUN-2000 10-NOV-2009
14643355 N-acyl 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline: the first orexin-2 receptor selective non-peptidic antagonist. 03-DEC-2003 10-NOV-2009
11741479 Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. 20-DEC-2001 07-DEC-2005
11741480 A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues. 20-DEC-2001 06-DEC-2005